Scribd Logo
Upload

Welcome to Scribd!

  • VTFT

    Uploaded by

    Ashish Mahale
    14 views1 page
    Girish Agencies' stock and sales statement from January 26th to February 18th shows opening stock of Rs. 1,17,585.13, stock received of Rs. 1,61,646.55, stock sold of Rs. 1,16,211.03 and closing stock of Rs. 1,63,020.65. Total purchase value during this period was Rs. 1,61,240 while total sales value at cost was Rs. 10,86,663.20 and total sales value at selling rate was Rs. 15,95,966.80. The statement provides details of stock levels and values of various intravenous medical products sold by the agency.

    Original Description:

    jkgkuknlnl;m

    Original Title

    VTFt

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Girish Agencies' stock and sales statement from January 26th to February 18th shows opening stock of Rs. 1,17,585.13, stock received of Rs. 1,61,646.55, stock sold of Rs. 1,16,211.03 and closing stock of Rs. 1,63,020.65. Total purchase value during this period was Rs. 1,61,240 while total sales value at cost was Rs. 10,86,663.20 and total sales value at selling rate was Rs. 15,95,966.80. The statement provides details of stock levels and values of various intravenous medical products sold by the agency.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    14 views1 page

    VTFT

    Uploaded by

    Ashish Mahale
    Girish Agencies' stock and sales statement from January 26th to February 18th shows opening stock of Rs. 1,17,585.13, stock received of Rs. 1,61,646.55, stock sold of Rs. 1,16,211.03 and closing stock of Rs. 1,63,020.65. Total purchase value during this period was Rs. 1,61,240 while total sales value at cost was Rs. 10,86,663.20 and total sales value at selling rate was Rs. 15,95,966.80. The statement provides details of stock levels and values of various intravenous medical products sold by the agency.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    Stock and Sales Statement file:///F:/MVGoldWholesaleLANIP/PrintFile.

    htm

    GIRISH AGENCIES
    4,BASEMENT,SAFALYA APTT,
    GOLE COLONY
    NASHIK-2.PH2576839,9371712846,9371809096
    Stock and Sales Statement
    Company : FRESENIUS KABI(VT)
    26/01/2023 to 18/02/2023

    Product Name Unit Op.St St-In St-Out Bal Value


    COMP.SOD.LACT(READY LACT)1000M 1000ML 0 0 0 0 0.00
    COMP.SOD.LACT.INJ(FREEFLEX) 500ML 0 0 0 0 0.00
    CONOX SENSOR 1 UNIT 10 0 6 4 3472.00
    DEXTROSE 5% 500ML FREEFLEX 500ML 2 0 0 2 98.92
    FRESOFOL 1% MCT/LCT 20ML 20ML 0 0 0 0 0.00
    KABILYTE 500ML 500ML 283 1240 560 963 102174.83
    KABIMIDINE 100MCG 2ML 2ML 0 0 0 0 0.00
    KABIPARA(PAREACETAMOL)I.V.100M 100ml 7 0 0 7 210.29
    KABITRAN 2.5ML 2.5 ML 165 0 0 165 7487.70
    NS IP 1000ML 1000ML 10 0 0 10 660.10
    SOD CHLORIDE INJ 0.9%(freeflex 500ML 162 0 100 62 4343.03
    SOD.CHLO.INJ .09% 100ML FREEFL 100 ML 22 0 0 22 658.72
    VOLULYTE 6% 500ML 1 60 0 61 23988.00
    VOLUVEN 500ML 196 1 124 73 19927.06
    Total Opening : 117585.13
    Total St-In : 161646.55
    Total St-Out : 116211.03
    Total Closing : 163020.65

    Total Purchase Value : 161240.00


    Total Sale Value(At Cost) : 108663.20
    Total Sale Value(At S.Rate): 159596.80

    1 of 1 18-02-2023, 18:59

    You might also like